Navidea Biopharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
42,699.50
35,726.70
27,563.50
14,309.00
74,945.90
16,117.20
Depreciation, Depletion & Amortization
404.20
500.20
571.40
501.40
254.60
150.40
Other Funds
659.00
130.50
23.90
-
-
745.50
Funds from Operations
36,899.00
27,550.10
17,911.60
9,548.50
84,273.50
16,712.30
Changes in Working Capital
1,287.00
1,576.70
1,164.40
13,105.30
25,189.90
13,834.80
Net Operating Cash Flow
35,612.10
29,126.70
19,076.00
3,556.80
59,083.60
2,877.60
Capital Expenditures
1,292.40
1,191.60
66.10
1.80
33.70
Sale of Fixed Assets & Businesses
-
-
38.30
45.00
-
Purchase/Sale of Investments
-
333.30
-
82.40
1,800.00
Net Investing Cash Flow
1,292.40
1,525.00
27.80
39.20
1,833.70
Issuance/Reduction of Debt, Net
21,833.10
3,234.20
20,261.60
4,156.90
61,067.80
Net Financing Cash Flow
60,724.90
3,191.70
20,791.10
4,143.20
60,995.40
Net Change in Cash
23,820.50
27,460.00
1,687.30
625.70
3,745.50
Free Cash Flow
36,851.70
30,241.20
19,115.00
3,554.90
59,049.90
Change in Capital Stock
39,550.80
88.00
553.40
13.60
72.40
About Navidea Biopharmaceuticals
View Profile
